Eventi e congressi | Poloinformativo HIV AIDS

Per saperne di più

Calendario Congressi di tutti i più importanti Eventi in Italia, in Europa e nel mondo che trattano di HIV AIDS ed epatiti. Report tradotti in italiano degli Eventi più importanti.

Calendario Congressi aggiornato da Poloinformativo HIV AIDS.
Chi volesse collaborare col sito ed inviarci segnalazioni di eventi o congressi può scrivere a:
redazione@poloinformativohiv.info

< 2018 >

Ottobre

Dom	Lun	Mar	Mer	Gio	Ven	Sab
settembre	1	2	3	4	5	6
7	8	9	10 Viral Hepatitis Elimination in PWID – treating the infections and predisposing causes Viral Hepatitis Elimination in PWID – treating the infections and predisposing causes Tutto il giorno 2018-10-10 San Patrignano Via S. Patrignano, 53, 47853 Coriano RN, Italia Via S. Patrignano, 53, 47853 Coriano RN, Italia https://www.poloinformativohiv.info/event/viral-hepatitis-elimination-in-pwid/ Viral Hepatitis Elimination in PWID – treating the infections and predisposing causes il 10 ottobre 2018 si terrà presso la Comunità di San Patrignano il Convegno “Viral Hepatitis Elimination in PWID – A Roadmap to Elimination in Italy: treating the infections and predisposing causes” (ID evento n. 150-234009 – 6 crediti formativi). L’evento, organizzato da EASL International Liver Foundation (EILF) e dalla Comunità di San Patrignano, rappresenta un momento unico di confronto e dibattito fra i maggiori esperti internazionali in Epatiti Virali, la comunità dei pazienti in Italia e tutte le principali parti interessate come funzionari governativi, associazioni di pazienti e società scientifiche di riferimento. Il Workshop si pone l’obiettivo di condividere e creare un piano di azione sull’eliminazione delle Epatiti Virali nei PWID (persone che consumano sostanze per via iniettiva) implementando la collaborazione tra infettivologi, epatologi, specialisti delle dipendenze e tutte le altre figure coinvolte in questo percorso. L’iscrizione è gratuita e sono ancora disponibili alcuni posti. Per iscriversi, è sufficiente compilare la scheda cliccando qui sotto. Il Provider Le confermerà l’avvenuta iscrizione. English version This one-day workshop entitled “Viral Hepatitis Elimination in PWID: A Roadmap to Elimination in Italy” is co-organised by EASL International Liver Foundation (EILF) and the San Patrignano Community and will bring together leading experts in viral hepatitis, the drug treatment community in Italy and key stakeholders such as government officials, industry representatives, patient organisations and scientific societies. The programme, presented by international experts, aims to provide the latest updates on viral hepatitis treatment in PWID while providing participants with the unique opportunity to network and exchange experiences and ideas for viral hepatitis elimination among people who inject drugs (PWID) in Italy. Bringing all the stakeholders together, this workshop aims to not only kick-start the call to action for viral hepatitis elimination in PWID in Italy but to also generate a multi-stakeholder plan of action to turn this vision into reality. We look forward to welcoming you to San Patrignano, Italy on 10 October 2018! Sito dell’evento: makevent.it	11	12	13
14	15	16	17	18	19	20
21 HIVR4P HIV Research for Prevention HIVR4P HIV Research for Prevention 15:46 2018-10-21-2018-10-24Europe/Rome Madrid Marriott Auditorium Hotel Av. de Aragón, 400, 28022 Madrid, Spagna Av. de Aragón, 400, 28022 Madrid, Spagna https://www.poloinformativohiv.info/event/hivr4p-hiv-research-for-prevention/ HIVR4P HIV Research for Prevention Madrid, 21-25 ottobre 2018 About HIVR4P HIV Research for Prevention (HIVR4P 2018) is the only global scientific conference focused exclusively on the challenging and fast-growing field of biomedical HIV prevention research. HIVR4P supports cross-fertilization among research on HIV vaccines, microbicides, PrEP, treatment as prevention, and other biomedical prevention approaches, while also providing a venue to discuss the research findings, questions, and priorities specific to each. The HIVR4P scientific program includes four days of plenary sessions by global leaders in HIV prevention research and policy; hundreds of new research studies presented in oral abstract and poster sessions; meet-the-expert lunches, symposia and roundtables; and pre-conference satellite sessions sponsored by research- and community-based organizations from around the world. Join an expected 1,500 leaders in HIV prevention research, programs, and policy at HIVR4P 2018, 21-25 October in Madrid. HIVR4P 2018 CO-CHAIRS Jose Alcami \| Instituto de Salud Carlos III, Spain Susan Buchbinder \| San Francisco Department of Public Health, USA Mike Chirenje \| University of Zimbabwe, Zimbabwe Georgia Tomaras \| Duke University, USA Fonte: fondazioneicona.org	22 HIVR4P HIV Research for Prevention HIVR4P HIV Research for Prevention 15:46 2018-10-22-2018-10-24Europe/Rome Madrid Marriott Auditorium Hotel Av. de Aragón, 400, 28022 Madrid, Spagna Av. de Aragón, 400, 28022 Madrid, Spagna https://www.poloinformativohiv.info/event/hivr4p-hiv-research-for-prevention/ HIVR4P HIV Research for Prevention Madrid, 21-25 ottobre 2018 About HIVR4P HIV Research for Prevention (HIVR4P 2018) is the only global scientific conference focused exclusively on the challenging and fast-growing field of biomedical HIV prevention research. HIVR4P supports cross-fertilization among research on HIV vaccines, microbicides, PrEP, treatment as prevention, and other biomedical prevention approaches, while also providing a venue to discuss the research findings, questions, and priorities specific to each. The HIVR4P scientific program includes four days of plenary sessions by global leaders in HIV prevention research and policy; hundreds of new research studies presented in oral abstract and poster sessions; meet-the-expert lunches, symposia and roundtables; and pre-conference satellite sessions sponsored by research- and community-based organizations from around the world. Join an expected 1,500 leaders in HIV prevention research, programs, and policy at HIVR4P 2018, 21-25 October in Madrid. HIVR4P 2018 CO-CHAIRS Jose Alcami \| Instituto de Salud Carlos III, Spain Susan Buchbinder \| San Francisco Department of Public Health, USA Mike Chirenje \| University of Zimbabwe, Zimbabwe Georgia Tomaras \| Duke University, USA Fonte: fondazioneicona.org	23 HIVR4P HIV Research for Prevention HIVR4P HIV Research for Prevention 15:46 2018-10-23-2018-10-24Europe/Rome Madrid Marriott Auditorium Hotel Av. de Aragón, 400, 28022 Madrid, Spagna Av. de Aragón, 400, 28022 Madrid, Spagna https://www.poloinformativohiv.info/event/hivr4p-hiv-research-for-prevention/ HIVR4P HIV Research for Prevention Madrid, 21-25 ottobre 2018 About HIVR4P HIV Research for Prevention (HIVR4P 2018) is the only global scientific conference focused exclusively on the challenging and fast-growing field of biomedical HIV prevention research. HIVR4P supports cross-fertilization among research on HIV vaccines, microbicides, PrEP, treatment as prevention, and other biomedical prevention approaches, while also providing a venue to discuss the research findings, questions, and priorities specific to each. The HIVR4P scientific program includes four days of plenary sessions by global leaders in HIV prevention research and policy; hundreds of new research studies presented in oral abstract and poster sessions; meet-the-expert lunches, symposia and roundtables; and pre-conference satellite sessions sponsored by research- and community-based organizations from around the world. Join an expected 1,500 leaders in HIV prevention research, programs, and policy at HIVR4P 2018, 21-25 October in Madrid. HIVR4P 2018 CO-CHAIRS Jose Alcami \| Instituto de Salud Carlos III, Spain Susan Buchbinder \| San Francisco Department of Public Health, USA Mike Chirenje \| University of Zimbabwe, Zimbabwe Georgia Tomaras \| Duke University, USA Fonte: fondazioneicona.org	24 HIVR4P HIV Research for Prevention HIVR4P HIV Research for Prevention 15:46 2018-10-24-2018-10-24Europe/Rome Madrid Marriott Auditorium Hotel Av. de Aragón, 400, 28022 Madrid, Spagna Av. de Aragón, 400, 28022 Madrid, Spagna https://www.poloinformativohiv.info/event/hivr4p-hiv-research-for-prevention/ HIVR4P HIV Research for Prevention Madrid, 21-25 ottobre 2018 About HIVR4P HIV Research for Prevention (HIVR4P 2018) is the only global scientific conference focused exclusively on the challenging and fast-growing field of biomedical HIV prevention research. HIVR4P supports cross-fertilization among research on HIV vaccines, microbicides, PrEP, treatment as prevention, and other biomedical prevention approaches, while also providing a venue to discuss the research findings, questions, and priorities specific to each. The HIVR4P scientific program includes four days of plenary sessions by global leaders in HIV prevention research and policy; hundreds of new research studies presented in oral abstract and poster sessions; meet-the-expert lunches, symposia and roundtables; and pre-conference satellite sessions sponsored by research- and community-based organizations from around the world. Join an expected 1,500 leaders in HIV prevention research, programs, and policy at HIVR4P 2018, 21-25 October in Madrid. HIVR4P 2018 CO-CHAIRS Jose Alcami \| Instituto de Salud Carlos III, Spain Susan Buchbinder \| San Francisco Department of Public Health, USA Mike Chirenje \| University of Zimbabwe, Zimbabwe Georgia Tomaras \| Duke University, USA Fonte: fondazioneicona.org	25	26	27
28 HIV Drug Therapy Glasgow 2018 Conference – 28 to 31 October 2018 HIV Drug Therapy Glasgow 2018 Conference – 28 to 31 October 2018 Tutto il giorno 2018-10-28-2018-10-31 Scottish Exhibition and Conference Centre Scottish Exhibition & Conference Centre, Glasgow G3 8YW, Regno Unito Scottish Exhibition & Conference Centre, Glasgow G3 8YW, Regno Unito https://www.poloinformativohiv.info/event/hiv-drug-therapy-glasgow-2018-conference-28-to-31-october-2018/ HIV Drug Therapy Glasgow 2018 Conference – 28 to 31 October 2018 HIV Drug Therapy- The programme is of interest to clinical investigators from across the globe to review current research and discuss its implications for HIV management strategies. Although there has been steady progress in HIV drug treatment, significant challenges still remain, including persistence of elevated risk of non-AIDS morbidity, with potential for HIV and/or antiretroviral therapy (ART) as causes, paediatric and adolescent care, models of care for the ageing population, and treatment issues throughout less well-resourced parts of Europe and the rest of the world. The Congress is also moving into areas beyond treatment, such as prevention, with time in the programme focussed on pre-exposure prophylaxis (PrEP) and issues across Europe and beyond. The important role of people living with HIV in treatment decisions and self-management continues to feature, and we look forward to a number of perspectives in the programme from the community. The programme maintains the plenary session presentation format. In addition to plenary presentations, the programme will include Keynote Lectures, the Lock Lecture, Industry Sessions and presentations based on abstracts submitted. The congress welcomes abstract submissions, and whilst only a small number can be accepted for oral presentation, we anticipate a sizeable display of Scientific Posters in the Congress Exhibition Hall throughout the Congress. Vai al sito della conferenza	29 HIV Drug Therapy Glasgow 2018 Conference – 28 to 31 October 2018 HIV Drug Therapy Glasgow 2018 Conference – 28 to 31 October 2018 Tutto il giorno 2018-10-29-2018-10-31 Scottish Exhibition and Conference Centre Scottish Exhibition & Conference Centre, Glasgow G3 8YW, Regno Unito Scottish Exhibition & Conference Centre, Glasgow G3 8YW, Regno Unito https://www.poloinformativohiv.info/event/hiv-drug-therapy-glasgow-2018-conference-28-to-31-october-2018/ HIV Drug Therapy Glasgow 2018 Conference – 28 to 31 October 2018 HIV Drug Therapy- The programme is of interest to clinical investigators from across the globe to review current research and discuss its implications for HIV management strategies. Although there has been steady progress in HIV drug treatment, significant challenges still remain, including persistence of elevated risk of non-AIDS morbidity, with potential for HIV and/or antiretroviral therapy (ART) as causes, paediatric and adolescent care, models of care for the ageing population, and treatment issues throughout less well-resourced parts of Europe and the rest of the world. The Congress is also moving into areas beyond treatment, such as prevention, with time in the programme focussed on pre-exposure prophylaxis (PrEP) and issues across Europe and beyond. The important role of people living with HIV in treatment decisions and self-management continues to feature, and we look forward to a number of perspectives in the programme from the community. The programme maintains the plenary session presentation format. In addition to plenary presentations, the programme will include Keynote Lectures, the Lock Lecture, Industry Sessions and presentations based on abstracts submitted. The congress welcomes abstract submissions, and whilst only a small number can be accepted for oral presentation, we anticipate a sizeable display of Scientific Posters in the Congress Exhibition Hall throughout the Congress. Vai al sito della conferenza	30 HIV Drug Therapy Glasgow 2018 Conference – 28 to 31 October 2018 HIV Drug Therapy Glasgow 2018 Conference – 28 to 31 October 2018 Tutto il giorno 2018-10-30-2018-10-31 Scottish Exhibition and Conference Centre Scottish Exhibition & Conference Centre, Glasgow G3 8YW, Regno Unito Scottish Exhibition & Conference Centre, Glasgow G3 8YW, Regno Unito https://www.poloinformativohiv.info/event/hiv-drug-therapy-glasgow-2018-conference-28-to-31-october-2018/ HIV Drug Therapy Glasgow 2018 Conference – 28 to 31 October 2018 HIV Drug Therapy- The programme is of interest to clinical investigators from across the globe to review current research and discuss its implications for HIV management strategies. Although there has been steady progress in HIV drug treatment, significant challenges still remain, including persistence of elevated risk of non-AIDS morbidity, with potential for HIV and/or antiretroviral therapy (ART) as causes, paediatric and adolescent care, models of care for the ageing population, and treatment issues throughout less well-resourced parts of Europe and the rest of the world. The Congress is also moving into areas beyond treatment, such as prevention, with time in the programme focussed on pre-exposure prophylaxis (PrEP) and issues across Europe and beyond. The important role of people living with HIV in treatment decisions and self-management continues to feature, and we look forward to a number of perspectives in the programme from the community. The programme maintains the plenary session presentation format. In addition to plenary presentations, the programme will include Keynote Lectures, the Lock Lecture, Industry Sessions and presentations based on abstracts submitted. The congress welcomes abstract submissions, and whilst only a small number can be accepted for oral presentation, we anticipate a sizeable display of Scientific Posters in the Congress Exhibition Hall throughout the Congress. Vai al sito della conferenza	31 HIV Drug Therapy Glasgow 2018 Conference – 28 to 31 October 2018 HIV Drug Therapy Glasgow 2018 Conference – 28 to 31 October 2018 Tutto il giorno 2018-10-31-2018-10-31 Scottish Exhibition and Conference Centre Scottish Exhibition & Conference Centre, Glasgow G3 8YW, Regno Unito Scottish Exhibition & Conference Centre, Glasgow G3 8YW, Regno Unito https://www.poloinformativohiv.info/event/hiv-drug-therapy-glasgow-2018-conference-28-to-31-october-2018/ HIV Drug Therapy Glasgow 2018 Conference – 28 to 31 October 2018 HIV Drug Therapy- The programme is of interest to clinical investigators from across the globe to review current research and discuss its implications for HIV management strategies. Although there has been steady progress in HIV drug treatment, significant challenges still remain, including persistence of elevated risk of non-AIDS morbidity, with potential for HIV and/or antiretroviral therapy (ART) as causes, paediatric and adolescent care, models of care for the ageing population, and treatment issues throughout less well-resourced parts of Europe and the rest of the world. The Congress is also moving into areas beyond treatment, such as prevention, with time in the programme focussed on pre-exposure prophylaxis (PrEP) and issues across Europe and beyond. The important role of people living with HIV in treatment decisions and self-management continues to feature, and we look forward to a number of perspectives in the programme from the community. The programme maintains the plenary session presentation format. In addition to plenary presentations, the programme will include Keynote Lectures, the Lock Lecture, Industry Sessions and presentations based on abstracts submitted. The congress welcomes abstract submissions, and whilst only a small number can be accepted for oral presentation, we anticipate a sizeable display of Scientific Posters in the Congress Exhibition Hall throughout the Congress. Vai al sito della conferenza	novembre	novembre	novembre

Questo sito Web utilizza i cookie per migliorare la tua esperienza. Daremo per scontato che ti stia bene, ma se lo desideri puoi disattivarli. Accetto Scopri di più